Tao Sun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Tao Sun has a total of 128 co-authors. Here are the top co-authors by number of shared publications:
Dong Liang
Paul C. Lauterbur Research Center for Biomedical Imaging, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, People's Republic of China
9 shared publicationsZhenguo Wang
Paul C. Lauterbur Research Center for Biomedical Imaging, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, People’s Republic of China
9 shared publicationsHairong Zheng
Paul C. Lauterbur Research Center for Biomedical Imaging, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, People’s Republic of China
8 shared publications- Meiyun Wang
Department of Radiology, Zhengzhou University People’s Hospital & Henan Provincial People’s Hospital, Zhengzhou, China
8 shared publications Yun Zhou
Central Research Institute United Imaging Healthcare Group Co., Ltd Shanghai China
8 shared publicationsYan Bai
Henan Provincial Peoples Hospital and Zhengzhou Peoples Hospital, Zhengzhou University, Zhengzhou, China
7 shared publications
Latest Publications
- Open Access
- 21 May 2026
- Published by Springer Nature in EJNMMI Research
- Vol. 16 (1)
From imaging heterogeneity to clinical decision: a novel imaging biomarker based on bone marrow kinetics for advanced NSCLC patients in partial response
Background: Risk of disease progression varies substantially among advanced non-small cell lung cancer (NSCLC) patients who achieve a partial response to initial therapy, and this subgroup currently lacks practical prognostic tools. This study aimed to develop a novel imaging biomarker by assessing bone marrow kinetic heterogeneity via pretreatment dynamic 18 F-fluorodeoxyglucose positron emission tomography/computed tomography ( 18 F-FDG PET/CT). We retrospectively analyzed 51 patients with advanced NSCLC, focusing on the 32 who attained a partial response following first-line treatment. Time-activity curves (TACs) from the tumor and bone marrow were metabolically decomposed. Through integrated analysis of clinical characteristics, conventional PET parameters, and 28 TAC-derived features, coupled with a rigorous bootstrap-LASSO-Cox procedure (1000 resamples) for robust feature selection, we developed a multivariate Cox model and a simplified risk-stratification model. Results: The bootstrap-LASSO-Cox analysis identified the slope of the bone marrow free FDG TAC between 10 and 30 min post-injection (BM_C f _Slope 10−30 ) as the most significant independent predictor. In the multivariate Cox model, this feature was strongly associated with a reduced risk of progression (Hazard Ratio = 0.10, 95% CI: 0.03–0.35, P < 0.001) and demonstrated good discriminative ability (C-index = 0.77, 95% CI: 0.68–0.86). Using an optimal cutoff value of -0.01119, this single parameter significantly stratified patients into high- and low-risk groups with distinct progression-free survival (Log-rank P < 0.001). The simplified model showed robust predictive performance, with average time-dependent AUCs of 0.792, 0.774, and 0.731 at 12, 18, and 24 months, respectively, and provided clinical net benefit. Neither conventional metabolic parameters nor clinical characteristics showed significant predictive value. Conclusion: For advanced NSCLC patients achieving an initial partial response, pretreatment assessment of bone marrow kinetics via dynamic 18 F-FDG PET/CT emerges as a potential prognostic biomarker. The TAC slope feature, which reflects early interstitial clearance, can identify patients at high risk of early progression, offering potential for personalizing surveillance strategies and guiding timely therapeutic interventions.
- 21 May 2026
- Published by Springer Nature in EJNMMI Research
- Vol. 16 (1)
Open AccessFrom imaging heterogeneity to clinical decision: a novel imaging biomarker based on bone marrow kinetics for advanced NSCLC patients in partial response
Background: Risk of disease progression varies substantially among advanced non-small cell lung cancer (NSCLC) patients who achieve a partial response to initial therapy, and this subgroup currently lacks practical prognostic tools. This study aimed to develop a novel imaging biomarker by assessing bone marrow kinetic heterogeneity via pretreatment dynamic 18 F-fluorodeoxyglucose positron emission tomography/computed tomography ( 18 F-FDG PET/CT). We retrospectively analyzed 51 patients with advanced NSCLC, focusing on the 32 who attained a partial response following first-line treatment. Time-activity curves (TACs) from the tumor and bone marrow were metabolically decomposed. Through integrated analysis of clinical characteristics, conventional PET parameters, and 28 TAC-derived features, coupled with a rigorous bootstrap-LASSO-Cox procedure (1000 resamples) for robust feature selection, we developed a multivariate Cox model and a simplified risk-stratification model. Results: The bootstrap-LASSO-Cox analysis identified the slope of the bone marrow free FDG TAC between 10 and 30 min post-injection (BM_C f _Slope 10−30 ) as the most significant independent predictor. In the multivariate Cox model, this feature was strongly associated with a reduced risk of progression (Hazard Ratio = 0.10, 95% CI: 0.03–0.35, P < 0.001) and demonstrated good discriminative ability (C-index = 0.77, 95% CI: 0.68–0.86). Using an optimal cutoff value of -0.01119, this single parameter significantly stratified patients into high- and low-risk groups with distinct progression-free survival (Log-rank P < 0.001). The simplified model showed robust predictive performance, with average time-dependent AUCs of 0.792, 0.774, and 0.731 at 12, 18, and 24 months, respectively, and provided clinical net benefit. Neither conventional metabolic parameters nor clinical characteristics showed significant predictive value. Conclusion: For advanced NSCLC patients achieving an initial partial response, pretreatment assessment of bone marrow kinetics via dynamic 18 F-FDG PET/CT emerges as a potential prognostic biomarker. The TAC slope feature, which reflects early interstitial clearance, can identify patients at high risk of early progression, offering potential for personalizing surveillance strategies and guiding timely therapeutic interventions.
- Open Access
- 2 April 2026
- Published by Springer Nature in EJNMMI Research
- Vol. 16 (1)
Multi-organ glucose metabolism alterations in diabetes mellitus: a total-body 18F-FDG PET/CT study
Diabetes mellitus (DM) is associated with systemic metabolic disturbances across multiple organs. Total-body 18F-fluorodeoxyglucose (F-FDG) PET/CT enables simultaneous quantification of glucose metabolism in numerous organs. This study aimed to characterize multi-organ 18F-FDG uptake patterns in type 2 DM patients compared with healthy controls and to explore associations with clinical variables including brain volume. Compared with controls, DM patients exhibited significantly lower SULmean in brain (− 15.3%, P < 0.001), left ventricular myocardium (− 12.7%, P < 0.001), and skull (− 9.8%, P = 0.003), and higher SULmean in subcutaneous adipose tissue (+ 18.2%, P = 0.004). Differences remained significant after multivariable adjustment. Brain volume showed moderate positive correlations with SUL values across multiple organs (r = 0.44–0.63, P < 0.01), and these associations remained significant after adjustment. DM duration negatively correlated with brain and skull SULmean (r = − 0.33 to − 0.46, P < 0.05). Type 2 DM is characterized by selective glucose hypometabolism in high-energy-demand organs and compensatory adipose activation. Independent associations with brain volume and disease duration suggest potential imaging biomarkers for diabetic complications using total-body PET/CT. The online version contains supplementary material available at 10.1186/s13550-026-01418-8.
- 2 April 2026
- Published by Springer Nature in EJNMMI Research
- Vol. 16 (1)
Open AccessMulti-organ glucose metabolism alterations in diabetes mellitus: a total-body 18F-FDG PET/CT study
Diabetes mellitus (DM) is associated with systemic metabolic disturbances across multiple organs. Total-body 18F-fluorodeoxyglucose (F-FDG) PET/CT enables simultaneous quantification of glucose metabolism in numerous organs. This study aimed to characterize multi-organ 18F-FDG uptake patterns in type 2 DM patients compared with healthy controls and to explore associations with clinical variables including brain volume. Compared with controls, DM patients exhibited significantly lower SULmean in brain (− 15.3%, P < 0.001), left ventricular myocardium (− 12.7%, P < 0.001), and skull (− 9.8%, P = 0.003), and higher SULmean in subcutaneous adipose tissue (+ 18.2%, P = 0.004). Differences remained significant after multivariable adjustment. Brain volume showed moderate positive correlations with SUL values across multiple organs (r = 0.44–0.63, P < 0.01), and these associations remained significant after adjustment. DM duration negatively correlated with brain and skull SULmean (r = − 0.33 to − 0.46, P < 0.05). Type 2 DM is characterized by selective glucose hypometabolism in high-energy-demand organs and compensatory adipose activation. Independent associations with brain volume and disease duration suggest potential imaging biomarkers for diabetic complications using total-body PET/CT. The online version contains supplementary material available at 10.1186/s13550-026-01418-8.
- Open Access
- 1 March 2026
- Published by AME Publishing Company in Quantitative Imaging in Medicine and Surgery
- Vol. 16 (3) , 249
Dynamic fluorine-18 fluorodeoxyglucose PET for evaluating different-sized metastatic lymph nodes in patients with non-small cell lung cancers
Background: For patients with non-small cell lung cancer (NSCLC), accurate and detailed lymph node (LN) staging is crucial for treatment planning and prognosis. However, reliably distinguishing metastatic from nonmetastatic LNs remains a clinical challenge, especially in small-sized LNs. A retrospective study was conducted to evaluate the ability of dynamic fluorine-18 fluorodeoxyglucose (F-18 FDG) positron emission tomography (PET), specifically the metabolic parameter of net influx rate (Ki), in distinguishing metastatic from and nonmetastatic LNs of different sizes in patients with NSCLC. Methods: In the study, 366 patients with lung nodules or masses detected on chest computed tomography (CT) scan underwent dynamic chest F-18 FDG PET/CT and static whole-body F-18 FDG PET/CT imaging after providing informed consent. A retrospective collection of 369 LNs in 98 patients with NSCLC was pathologically confirmed. CT features [density, maximum short diameter (Dmax), ratio of LN long diameter to short diameter (L/S), and ratio of LN density to muscle density (DR)] and static PET features [maximum standardized uptake value (SUVmax) and ratio of LN SUVmax to mediastinal blood pool SUVmax (SUVR)] of the LNs were measured. The Ki was also obtained through the application of an irreversible two-tissue compartment model. CT features, PET features, and Ki were compared between the metastatic and nonmetastatic LNs via the Wilcoxon rank-sum test. Receiver operating characteristic (ROC) analysis was performed for each parameter. Differences in area under the curve (AUC) were assessed via the DeLong test. Differences in sensitivity and specificity at a given threshold were compared using χ2 test. PResults: Among the 369 LNs, 172 were metastatic, and 197 were nonmetastatic. The CT features, static PET features, and Ki were significantly different between the metastatic and nonmetastatic LNs (Pmax, SUVmax, SUVR, and Ki were 0.852, 0.894, 0.888, and 0.936, respectively, while those of other features were max, 7.65 for SUVmax, 4.54 for SUVR, and 0.018 mL/g/min for Ki. The Delong test was carried out on the features with an AUC above 0.8 and showed that Ki had a higher diagnostic efficacy compared to the other features (Pmax ≥1 cm and Dmax max max ≥ 1 cm group. Conclusions: Compared with static PET features and CT features, the dynamic PET parameter Ki demonstrated superior diagnostic performance in differentiating metastatic from nonmetastatic LNs, particularly in the group of small LNs. After optimization of the cutoff value, the Ki improved the clinical applicability in identifying metastatic LNs.
- 1 March 2026
- Published by AME Publishing Company in Quantitative Imaging in Medicine and Surgery
- Vol. 16 (3) , 249
Open AccessDynamic fluorine-18 fluorodeoxyglucose PET for evaluating different-sized metastatic lymph nodes in patients with non-small cell lung cancers
Background: For patients with non-small cell lung cancer (NSCLC), accurate and detailed lymph node (LN) staging is crucial for treatment planning and prognosis. However, reliably distinguishing metastatic from nonmetastatic LNs remains a clinical challenge, especially in small-sized LNs. A retrospective study was conducted to evaluate the ability of dynamic fluorine-18 fluorodeoxyglucose (F-18 FDG) positron emission tomography (PET), specifically the metabolic parameter of net influx rate (Ki), in distinguishing metastatic from and nonmetastatic LNs of different sizes in patients with NSCLC. Methods: In the study, 366 patients with lung nodules or masses detected on chest computed tomography (CT) scan underwent dynamic chest F-18 FDG PET/CT and static whole-body F-18 FDG PET/CT imaging after providing informed consent. A retrospective collection of 369 LNs in 98 patients with NSCLC was pathologically confirmed. CT features [density, maximum short diameter (Dmax), ratio of LN long diameter to short diameter (L/S), and ratio of LN density to muscle density (DR)] and static PET features [maximum standardized uptake value (SUVmax) and ratio of LN SUVmax to mediastinal blood pool SUVmax (SUVR)] of the LNs were measured. The Ki was also obtained through the application of an irreversible two-tissue compartment model. CT features, PET features, and Ki were compared between the metastatic and nonmetastatic LNs via the Wilcoxon rank-sum test. Receiver operating characteristic (ROC) analysis was performed for each parameter. Differences in area under the curve (AUC) were assessed via the DeLong test. Differences in sensitivity and specificity at a given threshold were compared using χ2 test. PResults: Among the 369 LNs, 172 were metastatic, and 197 were nonmetastatic. The CT features, static PET features, and Ki were significantly different between the metastatic and nonmetastatic LNs (Pmax, SUVmax, SUVR, and Ki were 0.852, 0.894, 0.888, and 0.936, respectively, while those of other features were max, 7.65 for SUVmax, 4.54 for SUVR, and 0.018 mL/g/min for Ki. The Delong test was carried out on the features with an AUC above 0.8 and showed that Ki had a higher diagnostic efficacy compared to the other features (Pmax ≥1 cm and Dmax max max ≥ 1 cm group. Conclusions: Compared with static PET features and CT features, the dynamic PET parameter Ki demonstrated superior diagnostic performance in differentiating metastatic from nonmetastatic LNs, particularly in the group of small LNs. After optimization of the cutoff value, the Ki improved the clinical applicability in identifying metastatic LNs.
- Open Access
- 12 February 2026
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 16, 1752947
The value of metabolic parameters on dynamic 18F-FDG PET/CT for predicting lymph node metastasis in non-small cell lung cancer
Objectives: To evaluate the predictive value of dynamic 18 F-FDG PET/CT metabolic parameters of the primary tumor for mediastinal lymph node metastasis (LNM) in non-small cell lung cancer (NSCLC). Methods: A total of 316 patients with clinically suspected but untreated lung lesions who underwent dynamic PET/CT and static PET/CT scans from May 2021 to November 2024 were retrospectively collected in this study. Quantitative parameters including K1, k2, k3, and Ki of each lesion, were obtained by applying the irreversible two-tissue compartmental modeling using an in-house Matlab software. Time-activity curves (TACs) at the primary tumor were extracted from each dynamic 18 F-FDG PET/CT scan. The TAC signal was then decomposed into metabolism and blood flow components through kinetic modeling. Dynamic features including area under the curve (AUC), time-to-peak (t peak ), and slopes were then extracted from each component. Predictive analyses were performed using multivariate logistic regression to determine the predictive factors for LNM. Receiver-operating characteristic (ROC) analysis was performed to evaluate the predictive performance of models. Results: One hundred and fifteen patients who obtained LN biopsy within one month were enrolled in this study. Based on the results of the pathology, the patients were divided into LNM and non-LNM groups. The multivariate logistic regression analyses showed that the TLG, slope 10-30min , and CA125 were independent predictive factors for LNM ( P < 0.05, respectively). For the model comparison, composite model achieved the highest diagnostic efficacy (AUC of 0.867, sensitivity 75.5%, specificity 84.5%, accuracy 80.2%) compared with PET/CT model (AUC of 0.822, sensitivity 80.0%, specificity 72.4%, accuracy 75.7%) and clinical model (AUC of 0.792, sensitivity 49.1%, specificity 96.7%, accuracy 73.9%). Conclusion: The metabolic parameters based on dynamic and static 18 F-FDG PET/CT combined with CA125 can improve N-staging accuracy in patients with NSCLC.
- 12 February 2026
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 16, 1752947
Open AccessThe value of metabolic parameters on dynamic 18F-FDG PET/CT for predicting lymph node metastasis in non-small cell lung cancer
Objectives: To evaluate the predictive value of dynamic 18 F-FDG PET/CT metabolic parameters of the primary tumor for mediastinal lymph node metastasis (LNM) in non-small cell lung cancer (NSCLC). Methods: A total of 316 patients with clinically suspected but untreated lung lesions who underwent dynamic PET/CT and static PET/CT scans from May 2021 to November 2024 were retrospectively collected in this study. Quantitative parameters including K1, k2, k3, and Ki of each lesion, were obtained by applying the irreversible two-tissue compartmental modeling using an in-house Matlab software. Time-activity curves (TACs) at the primary tumor were extracted from each dynamic 18 F-FDG PET/CT scan. The TAC signal was then decomposed into metabolism and blood flow components through kinetic modeling. Dynamic features including area under the curve (AUC), time-to-peak (t peak ), and slopes were then extracted from each component. Predictive analyses were performed using multivariate logistic regression to determine the predictive factors for LNM. Receiver-operating characteristic (ROC) analysis was performed to evaluate the predictive performance of models. Results: One hundred and fifteen patients who obtained LN biopsy within one month were enrolled in this study. Based on the results of the pathology, the patients were divided into LNM and non-LNM groups. The multivariate logistic regression analyses showed that the TLG, slope 10-30min , and CA125 were independent predictive factors for LNM ( P < 0.05, respectively). For the model comparison, composite model achieved the highest diagnostic efficacy (AUC of 0.867, sensitivity 75.5%, specificity 84.5%, accuracy 80.2%) compared with PET/CT model (AUC of 0.822, sensitivity 80.0%, specificity 72.4%, accuracy 75.7%) and clinical model (AUC of 0.792, sensitivity 49.1%, specificity 96.7%, accuracy 73.9%). Conclusion: The metabolic parameters based on dynamic and static 18 F-FDG PET/CT combined with CA125 can improve N-staging accuracy in patients with NSCLC.
- Open Access
- 24 October 2025
- Published by Association for Computing Machinery (ACM)
- p. 573-578
Dynamic ¹⁸F-FDG-PET–Based Time-Series Analysis for Differentiating Benign and Malignant Pulmonary Lesions
- 24 October 2025
- Published by Association for Computing Machinery (ACM)
- p. 573-578
Open AccessDynamic ¹⁸F-FDG-PET–Based Time-Series Analysis for Differentiating Benign and Malignant Pulmonary Lesions
- Open Access
- 10 October 2025
- Published by Elsevier in NeuroImage
- Vol. 321, 121510
MR-guided graph learning of 18F-florbetapir PET enables accurate and interpretable Alzheimer’s disease staging
- 10 October 2025
- Published by Elsevier in NeuroImage
- Vol. 321, 121510
Open AccessMR-guided graph learning of 18F-florbetapir PET enables accurate and interpretable Alzheimer’s disease staging
- Open Access
- 2 September 2025
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 70 (17) , 17NT01
Effects of inter-crystal scattering events on the performance of SIAT aPET
Objective. The probability of 511 keV γ-rays undergoing inter-crystal scattering (ICS) in current positron emission tomography (PET) detectors is high. The objective of this research is to study the impact of the ICS events on the performance of the small animal SIAT aPET scanner. Approach. The SIAT aPET scanner is composed of 48 detectors organized in 4 rings with each ring containing 12 detectors. Each detector is composed of a 23 × 23 crystal array dual-ended read out by two 8 × 8 silicon photomultiplier arrays with resistor network circuits. In this work, a specific method was proposed to identify the single interaction (non-ICS) and ICS events (both interactions are undergoing ICS). A point source, two hot rod phantoms and a NEMA image quality (IQ) phantom were scanned and images were reconstructed using different types of events. Main results. The average full width at half maximum spatial resolutions of the point source obtained with all, non-ICS and ICS events are 0.62 mm, 0.52 mm, and 0.97 mm, respectively. The 1.0 mm diameter rods can be clearly resolved from the images of the ultra-micro hot rod phantom obtained with both all events and only the non-ICS events, but the image obtained with the non-ICS events show a 40% better peak-to-valley ratio for the 1.0 mm rods. The 1.35 mm rods can be clearly resolved from the image obtained with the ICS events. The images of the NEMA IQ phantom showed that the contrast recovery coefficients for hot rods with 1–5 mm diameters were improved by 24% in average, but the signal-to-noise ratio of the uniform region was decreased by 46% with the rejection of the ICS events (at least one γ-ray undergoing ICS). Significance. The results of this work provide useful guidance on whether it is necessary to use detectors that are capable of identifying the ICS events for PET scanners of different spatial resolution.
- 2 September 2025
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 70 (17) , 17NT01
Open AccessEffects of inter-crystal scattering events on the performance of SIAT aPET
Objective. The probability of 511 keV γ-rays undergoing inter-crystal scattering (ICS) in current positron emission tomography (PET) detectors is high. The objective of this research is to study the impact of the ICS events on the performance of the small animal SIAT aPET scanner. Approach. The SIAT aPET scanner is composed of 48 detectors organized in 4 rings with each ring containing 12 detectors. Each detector is composed of a 23 × 23 crystal array dual-ended read out by two 8 × 8 silicon photomultiplier arrays with resistor network circuits. In this work, a specific method was proposed to identify the single interaction (non-ICS) and ICS events (both interactions are undergoing ICS). A point source, two hot rod phantoms and a NEMA image quality (IQ) phantom were scanned and images were reconstructed using different types of events. Main results. The average full width at half maximum spatial resolutions of the point source obtained with all, non-ICS and ICS events are 0.62 mm, 0.52 mm, and 0.97 mm, respectively. The 1.0 mm diameter rods can be clearly resolved from the images of the ultra-micro hot rod phantom obtained with both all events and only the non-ICS events, but the image obtained with the non-ICS events show a 40% better peak-to-valley ratio for the 1.0 mm rods. The 1.35 mm rods can be clearly resolved from the image obtained with the ICS events. The images of the NEMA IQ phantom showed that the contrast recovery coefficients for hot rods with 1–5 mm diameters were improved by 24% in average, but the signal-to-noise ratio of the uniform region was decreased by 46% with the rejection of the ICS events (at least one γ-ray undergoing ICS). Significance. The results of this work provide useful guidance on whether it is necessary to use detectors that are capable of identifying the ICS events for PET scanners of different spatial resolution.
- Open Access
- 22 July 2025
- Published by Springer Nature in Cancer Imaging
- Vol. 25 (1) , 1-10
PSMA-PET-derived distance features as biomarkers for predicting outcomes in primary prostate cancer post-radical prostatectomy
Objectives: This study aims to assess the predictive capability of PSMA-PET imaging for disease outcomes in primary prostate cancer post-radical prostatectomy. In addition to conventional lesion uptake measures, the evaluation includes the distance of lesion to the prostate to enhance risk stratification and outcome prediction. Methods: A cohort of 190 men diagnosed with primary prostate cancer and undergoing prostatectomy were initially screened, resulting in 103 patients meeting the selection criteria. Imaging parameters, including lesion SUVmax, primary metabolic tumor volume (PMTV), maximum distance from the lesion to the prostate (Dmax), and total distances from the lesion to the prostate (Dtotal), were extracted from 68Ga-PSMA-11 PET images. Findings were dichotomized based on primary lesion uptake, the tumor volume size, Dmax distance, and the presence of metastatic disease. Postoperative biochemical recurrence-free survival (BCRFS) was analyzed using Kaplan–Meier survival plots and Log-rank tests. Furthermore, univariate and multivariate Cox regression analyses were performed to evaluate the association of PET parameters with survival outcomes. Results: Clinical and histopathological characteristics were summarized, including age, weight, height, metastasis status, baseline PSA, biopsy Gleason score, pt stage, margin status, and lymph node status. After a median follow-up of 20 months, 66 events occurred, with the estimated 3-year BCRFS being 46%. Increased PSMA intensity (SUVmax > 17.06) was associated with less favorable BCRFS (log-rank p = 0.017). Increased primary metabolic tumor volume (PMTV > 41.59 cm3) was also linked to less favorable BCRFS (log-rank p = 0.003). Dmax and Dtotal greater than 9.69 cm and 11.95 cm were identified as negative prognostic factors for BCRFS (log-rank p < 0.001 and p = 0.002, respectively). Based on PMTV and Dmax, patients were stratified into low-, intermediate-, and high-risk groups, with 3-year BCRFS rates of 57%, 31%, and 8%, respectively. Univariate Cox regression analysis revealed significant associations between BCRFS and factors such as baseline PSA (HR: 1.69, 95% CI 1.02–2.79, p = 0.042), SUVmax (HR: 1.56, 95% CI 1.04–1.91, p = 0.018), PMTV (HR: 2.05, 95% CI 1.26–3.34, p = 0.004), Dmax (HR: 2.24, 95% CI 1.37–3.65, p = 0.001), and Dtotal (HR: 2.11, 95% CI 1.29–3.45, p = 0.003). Multivariable Cox regression analysis identified the best model with PMTV (HR: 2.57, p = 0.004) and Dmax (HR: 1.98, p = 0.009) as independent predictors for biochemical recurrence (C-index = 0.68). Conclusion: The lesion distance to prostate was defined and assessed in conjunction with conventional PET parameters to facilitate preoperative risk stratification in primary prostate cancer following radical prostatectomy. The findings contribute to improved outcome prediction and emphasize the potential of PSMA-PET imaging in enhancing management strategies for prostate cancer patients. Clinical relevance: There is a critical need for non-invasive biomarkers that can predict treatment outcomes for patients with primary prostate cancer. Our study introduces the concept of using distance metrics, specifically the lesion distance to prostate in baseline PSMA-PET scans, to improve the prediction of biochemical recurrence following prostatectomy. These distance metrics consider the spatial distribution of lesions, offering a novel approach to assessing tumor spread and its implications for patient outcomes.
- 22 July 2025
- Published by Springer Nature in Cancer Imaging
- Vol. 25 (1) , 1-10
Open AccessPSMA-PET-derived distance features as biomarkers for predicting outcomes in primary prostate cancer post-radical prostatectomy
Objectives: This study aims to assess the predictive capability of PSMA-PET imaging for disease outcomes in primary prostate cancer post-radical prostatectomy. In addition to conventional lesion uptake measures, the evaluation includes the distance of lesion to the prostate to enhance risk stratification and outcome prediction. Methods: A cohort of 190 men diagnosed with primary prostate cancer and undergoing prostatectomy were initially screened, resulting in 103 patients meeting the selection criteria. Imaging parameters, including lesion SUVmax, primary metabolic tumor volume (PMTV), maximum distance from the lesion to the prostate (Dmax), and total distances from the lesion to the prostate (Dtotal), were extracted from 68Ga-PSMA-11 PET images. Findings were dichotomized based on primary lesion uptake, the tumor volume size, Dmax distance, and the presence of metastatic disease. Postoperative biochemical recurrence-free survival (BCRFS) was analyzed using Kaplan–Meier survival plots and Log-rank tests. Furthermore, univariate and multivariate Cox regression analyses were performed to evaluate the association of PET parameters with survival outcomes. Results: Clinical and histopathological characteristics were summarized, including age, weight, height, metastasis status, baseline PSA, biopsy Gleason score, pt stage, margin status, and lymph node status. After a median follow-up of 20 months, 66 events occurred, with the estimated 3-year BCRFS being 46%. Increased PSMA intensity (SUVmax > 17.06) was associated with less favorable BCRFS (log-rank p = 0.017). Increased primary metabolic tumor volume (PMTV > 41.59 cm3) was also linked to less favorable BCRFS (log-rank p = 0.003). Dmax and Dtotal greater than 9.69 cm and 11.95 cm were identified as negative prognostic factors for BCRFS (log-rank p < 0.001 and p = 0.002, respectively). Based on PMTV and Dmax, patients were stratified into low-, intermediate-, and high-risk groups, with 3-year BCRFS rates of 57%, 31%, and 8%, respectively. Univariate Cox regression analysis revealed significant associations between BCRFS and factors such as baseline PSA (HR: 1.69, 95% CI 1.02–2.79, p = 0.042), SUVmax (HR: 1.56, 95% CI 1.04–1.91, p = 0.018), PMTV (HR: 2.05, 95% CI 1.26–3.34, p = 0.004), Dmax (HR: 2.24, 95% CI 1.37–3.65, p = 0.001), and Dtotal (HR: 2.11, 95% CI 1.29–3.45, p = 0.003). Multivariable Cox regression analysis identified the best model with PMTV (HR: 2.57, p = 0.004) and Dmax (HR: 1.98, p = 0.009) as independent predictors for biochemical recurrence (C-index = 0.68). Conclusion: The lesion distance to prostate was defined and assessed in conjunction with conventional PET parameters to facilitate preoperative risk stratification in primary prostate cancer following radical prostatectomy. The findings contribute to improved outcome prediction and emphasize the potential of PSMA-PET imaging in enhancing management strategies for prostate cancer patients. Clinical relevance: There is a critical need for non-invasive biomarkers that can predict treatment outcomes for patients with primary prostate cancer. Our study introduces the concept of using distance metrics, specifically the lesion distance to prostate in baseline PSMA-PET scans, to improve the prediction of biochemical recurrence following prostatectomy. These distance metrics consider the spatial distribution of lesions, offering a novel approach to assessing tumor spread and its implications for patient outcomes.
- 20 May 2025
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 52 (13) , 5150-5164
The brain-white adipose tissue axis may play a crucial role in diabetes mellitus: a metabolic network analysis using total-body PET/CT imaging
This study aims to construct an individualized glucose metabolism network using total-body 18F-FDG PET imaging, which provides a comprehensive view of glucose metabolism across various organs, to explore the role of inter-organ interactions in Diabetes Mellitus (DM). In this study, we constructed covariance metabolic networks using static total-body PET images, normalized by lean body mass, from 36 patients with DM (DM group) and 36 age- and sex-matched healthy controls (HC group). Differences in network properties between the DM and HC groups were evaluated at both group and individual levels. In addition, correlation analysis was performed to explore the relationship between network properties and baseline clinical data in the DM subjects. We observed that the same edges in the first three edges with the largest values were brain-subcutaneous adipose tissue (SAT) and brain-visceral adipose tissue (VAT) at both group and individual levels. There was a positive correlation between the brain-VAT and BMI and there was a negative correlation between the brain-SAT and age. The most perturbed organ was the brain at both group and individual levels, and there was a positive correlation between the strength of abnormality of brain and age. This study successfully used static total-body PET imaging to construct individualized glucose metabolism networks for patients with DM, identifying the brain-VAT and brain-SAT as the most significantly altered edge and the brain as the most affected organ. These findings provide novel insights into the role of the brain-white adipose tissue axis in glucose metabolism in DM.
- 20 May 2025
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 52 (13) , 5150-5164
The brain-white adipose tissue axis may play a crucial role in diabetes mellitus: a metabolic network analysis using total-body PET/CT imaging
This study aims to construct an individualized glucose metabolism network using total-body 18F-FDG PET imaging, which provides a comprehensive view of glucose metabolism across various organs, to explore the role of inter-organ interactions in Diabetes Mellitus (DM). In this study, we constructed covariance metabolic networks using static total-body PET images, normalized by lean body mass, from 36 patients with DM (DM group) and 36 age- and sex-matched healthy controls (HC group). Differences in network properties between the DM and HC groups were evaluated at both group and individual levels. In addition, correlation analysis was performed to explore the relationship between network properties and baseline clinical data in the DM subjects. We observed that the same edges in the first three edges with the largest values were brain-subcutaneous adipose tissue (SAT) and brain-visceral adipose tissue (VAT) at both group and individual levels. There was a positive correlation between the brain-VAT and BMI and there was a negative correlation between the brain-SAT and age. The most perturbed organ was the brain at both group and individual levels, and there was a positive correlation between the strength of abnormality of brain and age. This study successfully used static total-body PET imaging to construct individualized glucose metabolism networks for patients with DM, identifying the brain-VAT and brain-SAT as the most significantly altered edge and the brain as the most affected organ. These findings provide novel insights into the role of the brain-white adipose tissue axis in glucose metabolism in DM.
- Open Access
- 1 May 2025
- Published by AME Publishing Company in Quantitative Imaging in Medicine and Surgery
- Vol. 15 (5) , 4274-4285
Utilizing temporal information to assess metabolic heterogeneity: a study of 18F-FDG dynamic positron emission tomography as a treatment response biomarker in small cell lung cancer
Original Article Utilizing temporal information to assess metabolic heterogeneity: a study of 18F-FDG dynamic positron emission tomography as a treatment response biomarker in small cell lung cancer Yubo Wang, Zhiheng Yao, Xinghua He, Jiuhui Zhao, Dehua Huang, Rongliang Wu, Xinyu Yang, Maoqun Zhang, Tao Sun, Ying Liang
- 1 May 2025
- Published by AME Publishing Company in Quantitative Imaging in Medicine and Surgery
- Vol. 15 (5) , 4274-4285
Open AccessUtilizing temporal information to assess metabolic heterogeneity: a study of 18F-FDG dynamic positron emission tomography as a treatment response biomarker in small cell lung cancer
Original Article Utilizing temporal information to assess metabolic heterogeneity: a study of 18F-FDG dynamic positron emission tomography as a treatment response biomarker in small cell lung cancer Yubo Wang, Zhiheng Yao, Xinghua He, Jiuhui Zhao, Dehua Huang, Rongliang Wu, Xinyu Yang, Maoqun Zhang, Tao Sun, Ying Liang